Latest filing published 10 Apr 2019 for Adamas Pharmaceuticals Inc.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Gregory T. Went: trading record in brief
All filings by Gregory T. Went on record concern Adamas Pharmaceuticals Inc. The record holds 54 filings, for trades running from 15 April 2014 to 8 April 2019.
Market trades split into 1 purchase (€44k) and 30 sales (€955k). Sales outweigh purchases by €911k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 5 share grants and 14 option exercises. 2019 to date brings no purchases and 1 sale.
The record was last updated on 10 April 2019 with a share grant in Adamas Pharmaceuticals Inc. The last purchase on record was published on 8 November 2018, which is 2,922 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gregory T. Went
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 56,250 shares0Common StockSEC:0001209191-19-024248:0
- 6,319 shares@ US$7.9950.4% of flowCommon StockSEC:0001209191-19-020763:0
- 3,850 shares@ US$12.9823.8% of flowCommon StockSEC:0001209191-18-057797:0Canonical exit: 5 Feb 2019 (T+90)
- 4,541 shares@ US$25.7510.3% of flowCommon StockSEC:0001209191-18-021318:0
- 20,625 shares0Common StockSEC:0001209191-18-018677:0
- 2,807 shares@ US$17.034.8% of flowCommon StockSEC:0001209191-17-022342:0
- 23,125 shares0Common StockSEC:0001209191-17-013940:0
- 117,450 shares0Common StockSEC:0001209191-16-145419:0
- 195,400 shares0Common StockSEC:0001209191-16-145419:1
- 204,900 shares@ US$1.8836.8% of flowCommon StockSEC:0001209191-16-128276:0
- 28,750 shares@ US$13.6638.6% of flowCommon StockSEC:0001209191-16-107117:0
- 500 shares@ US$1.88Common StockSEC:0001209191-15-042990:0
- 500 shares@ US$18.01Common StockSEC:0001209191-15-042990:1
- 1,800 shares@ US$18.00Common StockSEC:0001209191-15-042990:2
- 10,028 shares@ US$1.88Common StockSEC:0001209191-15-042990:3
- 28 shares@ US$18.00Common StockSEC:0001209191-15-042990:4
- 100 shares@ US$18.00Common StockSEC:0001209191-15-042990:5
- 100 shares@ US$1.88Common StockSEC:0001209191-15-042990:6
- 100 shares@ US$18.00Common StockSEC:0001209191-15-042990:7
- 200 shares@ US$18.00Common StockSEC:0001209191-15-042990:8
- 900 shares@ US$1.88Common StockSEC:0001209191-15-036405:0
- 900 shares@ US$18.00Common StockSEC:0001209191-15-036405:1
- 2,400 shares@ US$18.01Common StockSEC:0001209191-15-036405:2
- 2,610 shares@ US$1.88Common StockSEC:0001209191-15-035609:0
- 2,610 shares@ US$18.00Common StockSEC:0001209191-15-035609:1
25 of 53 declarations